The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients

Lasse Bremholm; Mads Hornum; Ulrik B Andersen; Bolette Hartmann; Jens Juul Holst; Palle Bekker Jeppesen

doi:10.1016/j.regpep.2011.03.003

The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients

Lasse Bremholm, Mads Hornum, Ulrik B Andersen, Bolette Hartmann, Jens Juul Holst, Palle Bekker Jeppesen

Department of Clinical Physiology, Nuclear Medicine & PET

80 Citations (Scopus)

Abstract

Exogenous Glucagon-Like Peptide-2 (GLP-2) treatment improves intestinal wet weight absorption in short bowel syndrome (SBS) patients. In healthy subjects, administration of GLP-2 increases small intestinal blood flow. The aim of the study was to evaluate the effect of GLP-2 on mesenteric blood flow and dynamic changes in cardiac parameters in SBS patients with jejunostomy and varying length of remnant small intestine.

Original language	English
Journal	Regulatory Peptides
Volume	168
Issue number	1-3
Pages (from-to)	32-8
Number of pages	7
ISSN	0167-0115
DOIs	https://doi.org/10.1016/j.regpep.2011.03.003
Publication status	Published - 7 Jun 2011

Access to Document

10.1016/j.regpep.2011.03.003

Cite this

@article{53e4490384164a93b2494e3d94d6f837,

title = "The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients",

abstract = "Exogenous Glucagon-Like Peptide-2 (GLP-2) treatment improves intestinal wet weight absorption in short bowel syndrome (SBS) patients. In healthy subjects, administration of GLP-2 increases small intestinal blood flow. The aim of the study was to evaluate the effect of GLP-2 on mesenteric blood flow and dynamic changes in cardiac parameters in SBS patients with jejunostomy and varying length of remnant small intestine.",

author = "Lasse Bremholm and Mads Hornum and Andersen, {Ulrik B} and Bolette Hartmann and Holst, {Jens Juul} and Jeppesen, {Palle Bekker}",

year = "2011",

month = jun,

day = "7",

doi = "10.1016/j.regpep.2011.03.003",

language = "English",

volume = "168",

pages = "32--8",

journal = "Regulatory Peptides",

issn = "0167-0115",

publisher = "Elsevier BV",

number = "1-3",

}

TY - JOUR

T1 - The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients

AU - Bremholm, Lasse

AU - Hornum, Mads

AU - Andersen, Ulrik B

AU - Hartmann, Bolette

AU - Holst, Jens Juul

AU - Jeppesen, Palle Bekker

PY - 2011/6/7

Y1 - 2011/6/7

N2 - Exogenous Glucagon-Like Peptide-2 (GLP-2) treatment improves intestinal wet weight absorption in short bowel syndrome (SBS) patients. In healthy subjects, administration of GLP-2 increases small intestinal blood flow. The aim of the study was to evaluate the effect of GLP-2 on mesenteric blood flow and dynamic changes in cardiac parameters in SBS patients with jejunostomy and varying length of remnant small intestine.

AB - Exogenous Glucagon-Like Peptide-2 (GLP-2) treatment improves intestinal wet weight absorption in short bowel syndrome (SBS) patients. In healthy subjects, administration of GLP-2 increases small intestinal blood flow. The aim of the study was to evaluate the effect of GLP-2 on mesenteric blood flow and dynamic changes in cardiac parameters in SBS patients with jejunostomy and varying length of remnant small intestine.

U2 - 10.1016/j.regpep.2011.03.003

DO - 10.1016/j.regpep.2011.03.003

M3 - Journal article

C2 - 21421014

SN - 0167-0115

VL - 168

SP - 32

EP - 38

JO - Regulatory Peptides

JF - Regulatory Peptides

IS - 1-3

ER -

The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients

Abstract

Access to Document

Fingerprint

Cite this